Streetbeat News

Stock Prices

BTAI

BioXcel Therapeutics Inc (NASDAQ:BTAI) announced positive topline results from a post-marketing study of Igalmi (dexmedetomidine) sublingual film, showing no evidence of tachyphylaxis, tolerance, or withdrawal. The study involved 28 inpatient adults with bipolar disorders or schizophrenia and demonstrated improvement in agitation symptoms with favorable safety results.

Portfolio Pulse from Vandana Singh

June 25, 2024 | 6:16 pm

WFC

Whales have shown a bullish stance on Wells Fargo (NYSE:WFC) with significant options activity. 47% of trades were bullish and 47% bearish, with a notable volume of calls and puts. Analysts have a consensus target price of $70.0, with Evercore ISI Group rating it as Outperform.

Portfolio Pulse from Benzinga Insights

June 25, 2024 | 6:16 pm

COP

Financial giants have shown a bullish interest in ConocoPhillips (NYSE:COP) through options trading, with a significant portion of trades being calls. Analysts have mixed ratings, but the consensus target price is $152.6. The stock is currently trading at $114.49.

Portfolio Pulse from Benzinga Insights

June 25, 2024 | 6:16 pm

UPS

Deep-pocketed investors have shown a bullish trend towards United Parcel Service (NYSE:UPS) with significant options activity. Benzinga's options scanner highlighted 18 extraordinary options activities, with 55% bullish and 33% bearish sentiment. The projected price targets range from $127.0 to $165.0. UPS is currently trading at $134.26, down 3.13%, with a neutral RSI. Analysts have mixed ratings with a consensus target price of $150.5.

Portfolio Pulse from Benzinga Insights

June 25, 2024 | 6:16 pm

CMCSA

DIS

FOX

PARA

STGW

WBD

Goldman Sachs analyst Michael Ng initiated coverage on several media stocks, highlighting Disney, Comcast, and Fox with Buy ratings due to their strong sports rights and streaming capabilities. Warner Bros. Discovery received a Neutral rating, while Paramount Global was given a Sell rating. Stagwell Inc also received a Neutral rating.

Portfolio Pulse from Chris Katje

June 25, 2024 | 6:12 pm

LLY

NVO

A study published in JAMA Network Open reveals that Novo Nordisk's older weight-loss drug Saxenda (liraglutide) is associated with decreased bone mass density. The study raises concerns about similar effects in newer treatments like Novo Nordisk's Wegovy and Eli Lilly's Zepbound.

Portfolio Pulse from Vandana Singh

June 25, 2024 | 6:12 pm

KLAC

KLA shares are trading higher amid a rebound in chip stocks.

Portfolio Pulse from Benzinga Newsdesk

June 25, 2024 | 6:10 pm

NVST

Envista Holdings (NYSE:NVST) has been analyzed by 5 analysts over the past three months, showing a range of ratings from bullish to bearish. The average 12-month price target has decreased to $19.9, down 22.27% from the previous $25.60. Analysts have recently lowered their ratings and price targets for NVST, reflecting a cautious outlook.

Portfolio Pulse from Benzinga Insights

June 25, 2024 | 6:01 pm

GE

Deep-pocketed investors have adopted a bearish approach towards GE Aero (NYSE:GE), with significant options activity indicating a potential price range of $160.0 to $175.0. The majority of the options trades are bearish, with 7 puts totaling $308,790 and 3 calls amounting to $179,328. The current trading volume is 2,317,494, with GE's price up by 1.8% at $163.43. An analyst from Deutsche Bank maintains a Buy rating with a target price of $209.0.

Portfolio Pulse from Benzinga Insights

June 25, 2024 | 6:01 pm

ALB

Deep-pocketed investors have adopted a bearish approach towards Albemarle (NYSE:ALB), as revealed by Benzinga's options scanner. The majority of the options activity is bearish, with significant puts and calls indicating a price range of $90.0 to $120.0. The stock is currently down 3.33% at $93.19, and analysts have mixed ratings with a consensus target price of $109.5.

Portfolio Pulse from Benzinga Insights

June 25, 2024 | 6:01 pm